Medicenna Therapeutics Corp. (NASDAQ:MDNA) Q3 2023 Earnings Call Transcript
Operator: Hello and welcome to the Medicenna Therapeutics Fiscal Third Quarter Earnings Call. All participants are now in a listen-only mode.
Medicenna Therapeutics Corp. (MDNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 2. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 3. | Hudson Bay Capital Management Sander Gerber | 0 | $0 | 0% | |
| 4. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 5. | AIGH Investment Partners Orin Hirschman | 0 | $0 | 0% |
Institutional Investors' Holdings
News See All
10 Penny Stocks To Buy That Are Too Cheap To Ignore
Out of the thousands of stocks that are traded on public markets and are available to retail investors, penny stocks rank right at the top of the list of favorites.
10 Best Fundamental Penny Stocks To Invest In
Penny stocks are volatile securities which are priced under $5. Their price tends to fluctuate wildly, and this attracts growth investors, as they are usually looking for very high returns quickly.
Hedge Funds Keep Buying Medicenna Therapeutics Corp. (MDNA)
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Billionaire Hedge Funds
